Primecap Management CO Neurocrine Biosciences Inc Transaction History
Primecap Management CO
- $127 Billion
- Q4 2024
A detailed history of Primecap Management CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Primecap Management CO holds 393,710 shares of NBIX stock, worth $46 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
393,710
Previous 404,000
2.55%
Holding current value
$46 Million
Previous $46.5 Million
15.54%
% of portfolio
0.04%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding NBIX
# of Institutions
647Shares Held
96.3MCall Options Held
599KPut Options Held
554K-
Black Rock Inc. New York, NY14.2MShares$1.66 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.18 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$572 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$353 Million0.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.49MShares$291 Million0.54% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...